These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 359016)

  • 1. Plasma bromocriptine levels, clinical and growth hormone responses in Parkinsonism.
    Price P; Debono A; Parkes JD; Marsden CD; Rosenthaler J
    Br J Clin Pharmacol; 1978 Oct; 6(4):303-9. PubMed ID: 359016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa.
    Parkes JD; Debono AG; Marsden CD
    J Neurol Neurosurg Psychiatry; 1976 Nov; 39(11):1101-8. PubMed ID: 1036999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine aspects of bromocriptine therapy in Parkinsonism.
    Shaw KM; Lees AJ; Franks S; Daggett P; Thompson BD; Stern GM
    J Neural Transm; 1978; 43(2):153-60. PubMed ID: 104006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter: Growth-hormone response to bromocriptine in parkinsonism.
    Shaw KM; Lees AJ; Hayes S; Ross EJ; Stern GM; Thompson BD
    Lancet; 1976 Jan; 1(7952):194. PubMed ID: 54702
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutical effects of bromocriptine (CB 154) in 10 acromegalic subjects. Study of somatotrophic function and clinical survey (author's transl)].
    Fossati P; Asfour M; Brion-Brevan B; Fourlinnie JC; Cappoen JP; Dalle-Furnari MA; Blacker C
    Ann Endocrinol (Paris); 1977; 38(4):291-301. PubMed ID: 332054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromocriptine and dopamine receptor stimulation.
    Debono AG; Marsden CD; Asselman P; Parkes JD
    Br J Clin Pharmacol; 1976 Dec; 3(6):977-82. PubMed ID: 22216518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bromocriptine treatment in Parkinson's disease.
    Parkes JD; Marsden CD; Donaldson I; Galea-Debono A; Walters J; Kennedy G; Asselman P
    J Neurol Neurosurg Psychiatry; 1976 Feb; 39(2):184-93. PubMed ID: 772175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of bromocriptine on maturity onset diabetes.
    Barnett AH; Chapman C; Gailer K; Hayter CJ
    Postgrad Med J; 1980 Jan; 56(651):11-4. PubMed ID: 6992131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromocriptine and domperidone in the treatment of Parkinson disease.
    Quinn N; Illas A; Lhermitte F; Agid Y
    Neurology; 1981 Jun; 31(6):662-7. PubMed ID: 7195483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metoclopramide blocks bromocriptine induced antihypertensive effect in hypertensive patients.
    Luchsinger A; Grilli M; Forte P; Morales E; Velasco M
    Int J Clin Pharmacol Ther; 1995 Sep; 33(9):509-12. PubMed ID: 8520809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of food and metoclopramide on the pharmacokinetics and side effects of bromocriptine.
    Kopitar Z; Vrhovac B; Povsic L; Plavsić F; Francetić I; Urbancic J
    Eur J Drug Metab Pharmacokinet; 1991; 16(3):177-81. PubMed ID: 1814735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of small doses of bromocriptine (Parlodel) on the serum level of growth hormone in acromegaly].
    Gáspár L; László F
    Orv Hetil; 1980 May; 121(20):1179-82. PubMed ID: 7413200
    [No Abstract]   [Full Text] [Related]  

  • 13. Acromegaly--results of long term treatment with bromocriptine.
    Besser GM; Wass JA; Thorner MO
    Acta Endocrinol Suppl (Copenh); 1978; 216():187-98. PubMed ID: 347861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of acromegaly using bromocriptine].
    Köbberling J; Schwinn G; Dirks H
    Dtsch Med Wochenschr; 1975 Jul; 100(29):1540-2. PubMed ID: 1149634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of bromocriptine in the treatment of Parkinson's disease.
    Mackenzie RA; Lance JW
    Clin Exp Neurol; 1978; 15():228-36. PubMed ID: 386307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromocriptine in Parkinsonism.
    Pearce I; Pearce JM
    Br Med J; 1978 May; 1(6124):1402-4. PubMed ID: 348261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between lergotrile and bromocriptine in parkinsonism.
    Teychenne PF; Pfeiffer RF; Bern SM; McInturff D; Calne DB
    Ann Neurol; 1978 Apr; 3(4):319-24. PubMed ID: 666273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of bromocriptine during continuous oral treatment of Parkinson's disease.
    Friis ML; Grøn U; Larsen NE; Pakkenberg H; Hvidberg EF
    Eur J Clin Pharmacol; 1979 May; 15(4):275-80. PubMed ID: 477712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic studies with bromocriptine in patients with idiopathic parkinsonism and Huntington's chorea.
    Kartzinel R; Perlow MD; Carter AC; Chase TN; Calne DB; Shoulson I
    Trans Am Neurol Assoc; 1976; 101():53-6. PubMed ID: 141763
    [No Abstract]   [Full Text] [Related]  

  • 20. Dopaminergic stimulation and inhibition of growth hormone secretion in normal man: studies of the pharmacologic specificity.
    Bansal SA; Lee LA; Woolf PD
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1273-7. PubMed ID: 7028777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.